Direct oral anticoagulants versus vitamin K antagonists after recent ischemic stroke in patients with atrial fibrillation.
Seiffge D, Paciaroni M, Wilson D, Koga M, Macha K, Cappellari M, Schaedelin S, Shakeshaft C, Takagi M, Tsivgoulis G, Bonetti B, Kallmünzer B, Arihiro S, Alberti A, Polymeris A, Ambler G, Yoshimura S, Venti M, Bonati L, Muir K, Yamagami H, Thilemann S, Altavilla R, Peters N, Inoue M, Bobinger T, Agnelli G, Brown M, Sato S, Acciarresi M, Jäger H, Bovi P, Schwab S, Lyrer P, Caso V, Toyoda K, Werring D, Engelter S, De Marchis G, CROMIS-2, RAF, RAF-DOAC, SAMURAI, NOACISP LONGTERM, Erlangen and Verona registry collaborators. Direct oral anticoagulants versus vitamin K antagonists after recent ischemic stroke in patients with atrial fibrillation. Ann Neurol 2019; 85:823-834.
30.04.2019
Direct oral anticoagulants versus vitamin K antagonists after recent ischemic stroke in patients with atrial fibrillation.
30.04.2019
Ann Neurol 2019; 85:823-834
Seiffge David Julian, Paciaroni Maurizio, Wilson Duncan, Koga Masatoshi, Macha Kosmas, Cappellari Manuel, Schaedelin Sabine A, Shakeshaft Clare, Takagi Masahito, Tsivgoulis Georgios, Bonetti Bruno, Kallmünzer Bernd, Arihiro Shoji, Alberti Andrea, Polymeris Alexandros A, Ambler Gareth, Yoshimura Sohei, Venti Michele, Bonati Leo H, Muir Keith, Yamagami Hiroshi, Thilemann Sebastian, Altavilla Riccardo, Peters Nils, Inoue Manabu, Bobinger Tobias, Agnelli Giancarlo, Brown Martin M, Sato Shoichiro, Acciarresi Monica, Jäger Hans Rolf, Bovi Paolo, Schwab Stefan, Lyrer Philippe A, Caso Valeria, Toyoda Kazunori, Werring David J, Engelter Stefan T, De Marchis Gian Marco, CROMIS-2, RAF, RAF-DOAC, SAMURAI, NOACISP LONGTERM, Erlangen and Verona registry collaborators
Weiter